Koichi Hashimoto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Koichi Hashimoto has a total of 273 co-authors. Here are the top co-authors by number of shared publications:
- Mitsuaki Hosoya
Department of Pediatrics Fukushima Medical University School of Medicine Fukushima Japan
29 shared publications Mitsuaki Hosoya
Fukushima Regional Centre for the Japan Environment and Children's Study, Fukushima Medical University, Fukushima 960-1295
18 shared publications- Seiji Yasumura
Radiation Medical Science Center for the Fukushima Health Management Survey Fukushima Medical University Fukushima Japan
15 shared publications - Hidekazu Nishigori
Department of Development and Environmental Medicine, Fukushima Medical Center for Children and Women, Graduate School of Medicine, Fukushima Medical University, Fukushima, Japan
11 shared publications - Hyo Kyozuka
Obstetrics and Gynaecology, Ohta Nishinouchi Hospital, Koriyama, JPN
11 shared publications - Yohei Kume
Department of Pediatrics Fukushima Medical University School of Medicine Fukushima Japan
11 shared publications
Latest Publications
- 23 October 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (10)
Maternal Parenting Styles and Nighttime Diaper Use in Early Childhood: The Japan Environment and Children's Study
Purpose: To examine cross‐sectional and longitudinal associations between maternal parenting style and nighttime diaper use in early childhood. Methods: We analyzed data from the Japan Environment and Children's Study, a nationwide prospective birth cohort. Maternal parenting styles were categorized as Authoritative, Authoritarian, Permissive, or Uninvolved using responsiveness and demandingness scores from a validated parenting attitude questionnaire. Nighttime diaper use was assessed at ages 3 and 4 years. Multivariable modified Poisson regression with robust error variance was applied to estimate adjusted prevalence ratios (aPRs) for nighttime diaper use at age 3 and adjusted risk ratios (aRRs) for its persistence from ages 3 to 4. Results: The cross‐sectional and longitudinal analyses included 65 765 and 54 915 mother–child pairs, respectively. Compared with the Uninvolved style, aPRs for nighttime diaper use at age 3 were 0.96 (95% CI, 0.95–0.97) for Authoritative, 0.99 (95% CI, 0.98–1.00) for Authoritarian, and 0.99 (95% CI, 0.99–1.00) for Permissive styles. The corresponding aRRs for persistent nighttime diaper use were 0.93 (95% CI, 0.91–0.95), 0.96 (95% CI, 0.94–0.98), and 0.98 (95% CI, 0.96–1.01). No significant interaction was found with child sex, whereas a significant interaction was observed between child developmental status and Authoritarian style. Conclusions: Maternal parenting styles were associated with nighttime diaper use at age 3 and its persistence at age 4. Although nighttime diaper use is not a direct measure of nocturnal continence, these findings suggest that maternal caregiving context may be relevant to early nighttime diaper discontinuation before school age. Trial Registration: ClinicalTrials.gov identifier: UMIN000030786
- 23 October 2026
- Published by Wiley in International Journal of Urology
- Vol. 33 (10)
Maternal Parenting Styles and Nighttime Diaper Use in Early Childhood: The Japan Environment and Children's Study
Purpose: To examine cross‐sectional and longitudinal associations between maternal parenting style and nighttime diaper use in early childhood. Methods: We analyzed data from the Japan Environment and Children's Study, a nationwide prospective birth cohort. Maternal parenting styles were categorized as Authoritative, Authoritarian, Permissive, or Uninvolved using responsiveness and demandingness scores from a validated parenting attitude questionnaire. Nighttime diaper use was assessed at ages 3 and 4 years. Multivariable modified Poisson regression with robust error variance was applied to estimate adjusted prevalence ratios (aPRs) for nighttime diaper use at age 3 and adjusted risk ratios (aRRs) for its persistence from ages 3 to 4. Results: The cross‐sectional and longitudinal analyses included 65 765 and 54 915 mother–child pairs, respectively. Compared with the Uninvolved style, aPRs for nighttime diaper use at age 3 were 0.96 (95% CI, 0.95–0.97) for Authoritative, 0.99 (95% CI, 0.98–1.00) for Authoritarian, and 0.99 (95% CI, 0.99–1.00) for Permissive styles. The corresponding aRRs for persistent nighttime diaper use were 0.93 (95% CI, 0.91–0.95), 0.96 (95% CI, 0.94–0.98), and 0.98 (95% CI, 0.96–1.01). No significant interaction was found with child sex, whereas a significant interaction was observed between child developmental status and Authoritarian style. Conclusions: Maternal parenting styles were associated with nighttime diaper use at age 3 and its persistence at age 4. Although nighttime diaper use is not a direct measure of nocturnal continence, these findings suggest that maternal caregiving context may be relevant to early nighttime diaper discontinuation before school age. Trial Registration: ClinicalTrials.gov identifier: UMIN000030786
- Open Access
- 5 October 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (11)
Early childhood changes in BMI z-score and serum IGF-1 levels at age 6 years: the Japan environment and children study
Body mass index (BMI) is associated with insulin-like growth factor-1 (IGF-1) concentrations in children, but longitudinal evidence regarding BMI changes during early childhood and IGF-1 concentrations at age 6 years remains limited. We examined associations between early childhood BMI z-score changes and serum IGF-1 concentrations at age 6 years in 2757 children from the Japan Environment and Children's Study. BMI z-scores were assessed at ages 2, 4, and 6 years, and serum IGF-1 was measured at age 6 years. Associations of overall BMI z-score change from ages 2 to 6 years and interval-specific changes from ages 2 to 4 and 4 to 6 years with IGF-1 were examined using multivariable linear regression. Longitudinal associations of repeated BMI z-scores with thyroid-stimulating hormone (TSH), free thyroxine (FT4), and 25-hydroxyvitamin D [25(OH)D] were evaluated using linear mixed-effects models. Overall BMI z-score change from ages 2 to 6 years was positively associated with IGF-1 (B = 18.14 ng/mL; 95% confidence interval [CI], 16.34-19.95; P < .001). When interval-specific changes were simultaneously modeled, changes from ages 2 to 4 years (B = 11.43; 95% CI, 8.82-14.15) and 4 to 6 years (B = 21.24; 95% CI, 18.94-23.54) were both associated with IGF-1 (both P < .001). Associations with TSH and FT4 were weaker and inconsistent, while the age-dependent association with 25(OH)D was attenuated after adjustment for season of blood collection. These findings suggest that changes in body size during early childhood are associated with variation in serum IGF-1 concentrations at school age.
- 5 October 2026
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 10 (11)
Open AccessEarly childhood changes in BMI z-score and serum IGF-1 levels at age 6 years: the Japan environment and children study
Body mass index (BMI) is associated with insulin-like growth factor-1 (IGF-1) concentrations in children, but longitudinal evidence regarding BMI changes during early childhood and IGF-1 concentrations at age 6 years remains limited. We examined associations between early childhood BMI z-score changes and serum IGF-1 concentrations at age 6 years in 2757 children from the Japan Environment and Children's Study. BMI z-scores were assessed at ages 2, 4, and 6 years, and serum IGF-1 was measured at age 6 years. Associations of overall BMI z-score change from ages 2 to 6 years and interval-specific changes from ages 2 to 4 and 4 to 6 years with IGF-1 were examined using multivariable linear regression. Longitudinal associations of repeated BMI z-scores with thyroid-stimulating hormone (TSH), free thyroxine (FT4), and 25-hydroxyvitamin D [25(OH)D] were evaluated using linear mixed-effects models. Overall BMI z-score change from ages 2 to 6 years was positively associated with IGF-1 (B = 18.14 ng/mL; 95% confidence interval [CI], 16.34-19.95; P < .001). When interval-specific changes were simultaneously modeled, changes from ages 2 to 4 years (B = 11.43; 95% CI, 8.82-14.15) and 4 to 6 years (B = 21.24; 95% CI, 18.94-23.54) were both associated with IGF-1 (both P < .001). Associations with TSH and FT4 were weaker and inconsistent, while the age-dependent association with 25(OH)D was attenuated after adjustment for season of blood collection. These findings suggest that changes in body size during early childhood are associated with variation in serum IGF-1 concentrations at school age.
- 24 July 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (7) , e70448
Reply to Topal et al.
- 24 July 2026
- Published by Wiley in Pediatric Allergy and Immunology
- Vol. 37 (7) , e70448
Reply to Topal et al.
- Open Access
- 14 May 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (5) , 002269
Establishment of a human coronavirus HKU1 infection evaluation system using apical-out airway organoids
Human coronavirus HKU1 (HCoV-HKU1) is difficult to study because it does not propagate in standard cell lines. Consequently, research has relied on the air–liquid interface model, which is limited by long culture periods and the absence of cytopathic effects (CPEs). To address these challenges, we established an infection evaluation system using apical-out airway organoids (AOAOs). Derived from human bronchial epithelial cells, AOAOs supported efficient HCoV-HKU1 replication, and immunofluorescence revealed a preferential infection of ciliated cells. Notably, HCoV-HKU1 induced a distinct CPE characterized by organoid dissociation, enabling the quantification of viral titres via the TCID 50 assay. Applying this model to antiviral testing, the serine protease inhibitor nafamostat effectively inhibited viral infection and CPE, consistent with the known entry mechanism. Thus, AOAOs provide a rapid, scalable and reproducible platform for HCoV-HKU1 research, overcoming limitations of traditional systems. This approach enables reliable viral replication analysis, titre determination and drug evaluation and may accelerate research on difficult-to-culture respiratory viruses.
- 14 May 2026
- Published by Microbiology Society in Journal of General Virology
- Vol. 107 (5) , 002269
Open AccessEstablishment of a human coronavirus HKU1 infection evaluation system using apical-out airway organoids
Human coronavirus HKU1 (HCoV-HKU1) is difficult to study because it does not propagate in standard cell lines. Consequently, research has relied on the air–liquid interface model, which is limited by long culture periods and the absence of cytopathic effects (CPEs). To address these challenges, we established an infection evaluation system using apical-out airway organoids (AOAOs). Derived from human bronchial epithelial cells, AOAOs supported efficient HCoV-HKU1 replication, and immunofluorescence revealed a preferential infection of ciliated cells. Notably, HCoV-HKU1 induced a distinct CPE characterized by organoid dissociation, enabling the quantification of viral titres via the TCID 50 assay. Applying this model to antiviral testing, the serine protease inhibitor nafamostat effectively inhibited viral infection and CPE, consistent with the known entry mechanism. Thus, AOAOs provide a rapid, scalable and reproducible platform for HCoV-HKU1 research, overcoming limitations of traditional systems. This approach enables reliable viral replication analysis, titre determination and drug evaluation and may accelerate research on difficult-to-culture respiratory viruses.
- Open Access
- 12 May 2026
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (5) , 002165
Temporal genetic changes in human bocavirus 1 in Fukushima, Japan, from 2018 to 2024
Introduction. Human bocavirus 1 (HBoV1) is a member of Bocaparvovirus primate1 and is associated with paediatric respiratory infections. Although genetic grouping has been described, it remains unclear whether temporal genetic changes occur among clinically circulating HBoV1 strains. Hypothesis/Gap Statement. HBoV1 shows limited genetic diversity, but temporal genetic changes may occur in circulating strains. Aim. To investigate whether temporal genetic changes are present in HBoV1 isolates collected in Fukushima, Japan, between 2018 and 2024. Methodology. Nasopharyngeal swabs were collected from paediatric inpatients with acute respiratory infections. Thirty-two HBoV1 isolates were obtained using air–liquid interface cultures of human bronchial/tracheal epithelial cells. Nearly complete genomes were sequenced by next-generation sequencing and analysed together with additional reference sequences (total n =100, including outgroups) using phylogenetic and time-scaled methods. Results. Phylogenetic analyses classified the 32 Fukushima isolates into Group 1 ( n =12) and Group 2 ( n =20). Group 2 predominated in 2018, Group 1 from 2019 to 2021 and Group 2 again from 2022 to 2024, indicating temporal shifts in circulating strains. The average number of nucleotide differences among HBoV1 genomes was 13.9 (maximum 55), with Groups 1 and 2 diverging around 2004–2005. Divergence was concentrated in the VP genes, and synonymous substitutions within VP genes overlapped the ORFx reading frame, leading to distinct amino acid differences in ORFx. Conclusion. Clinically circulating HBoV1 undergoes temporal genetic change, with group differentiation determined primarily by VP genes and uniquely by ORFx at the amino acid level. These findings suggest a potential biological role for ORFx in the HBoV1 life cycle. Understanding these temporal genetic shifts is important for enhancing the accuracy of molecular surveillance tools, particularly for distinguishing genetically diverse HBoV1 strains.
- 12 May 2026
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 75 (5) , 002165
Open AccessTemporal genetic changes in human bocavirus 1 in Fukushima, Japan, from 2018 to 2024
Introduction. Human bocavirus 1 (HBoV1) is a member of Bocaparvovirus primate1 and is associated with paediatric respiratory infections. Although genetic grouping has been described, it remains unclear whether temporal genetic changes occur among clinically circulating HBoV1 strains. Hypothesis/Gap Statement. HBoV1 shows limited genetic diversity, but temporal genetic changes may occur in circulating strains. Aim. To investigate whether temporal genetic changes are present in HBoV1 isolates collected in Fukushima, Japan, between 2018 and 2024. Methodology. Nasopharyngeal swabs were collected from paediatric inpatients with acute respiratory infections. Thirty-two HBoV1 isolates were obtained using air–liquid interface cultures of human bronchial/tracheal epithelial cells. Nearly complete genomes were sequenced by next-generation sequencing and analysed together with additional reference sequences (total n =100, including outgroups) using phylogenetic and time-scaled methods. Results. Phylogenetic analyses classified the 32 Fukushima isolates into Group 1 ( n =12) and Group 2 ( n =20). Group 2 predominated in 2018, Group 1 from 2019 to 2021 and Group 2 again from 2022 to 2024, indicating temporal shifts in circulating strains. The average number of nucleotide differences among HBoV1 genomes was 13.9 (maximum 55), with Groups 1 and 2 diverging around 2004–2005. Divergence was concentrated in the VP genes, and synonymous substitutions within VP genes overlapped the ORFx reading frame, leading to distinct amino acid differences in ORFx. Conclusion. Clinically circulating HBoV1 undergoes temporal genetic change, with group differentiation determined primarily by VP genes and uniquely by ORFx at the amino acid level. These findings suggest a potential biological role for ORFx in the HBoV1 life cycle. Understanding these temporal genetic shifts is important for enhancing the accuracy of molecular surveillance tools, particularly for distinguishing genetically diverse HBoV1 strains.
- Open Access
- 13 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Effects of external radiation dose on pediatric peripheral blood components after the Great East Japan Earthquake: Fukushima Health Management Survey
The online version contains supplementary material available at 10.1038/s41598-026-47787-x.
- 13 April 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessEffects of external radiation dose on pediatric peripheral blood components after the Great East Japan Earthquake: Fukushima Health Management Survey
The online version contains supplementary material available at 10.1038/s41598-026-47787-x.
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1)
Pneumococcal Serotypes Isolated From Invasive Infections in Children in Fukushima Prefecture From 2016 to 2025
- 1 January 2026
- Published by Wiley in Pediatrics International
- Vol. 68 (1)
Pneumococcal Serotypes Isolated From Invasive Infections in Children in Fukushima Prefecture From 2016 to 2025
- 18 July 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (2) , 334-341
Respiratory Syncytial Virus Fusion Protein Epitope-Specific Antibodies and Neutralizing Activities Against Various Respiratory Syncytial Virus Strains
Background: Respiratory syncytial virus (RSV) fusion protein contains major neutralizing epitopes (sites II, III, IV, V, and Ø), targeted by new vaccines and monoclonal antibodies. However, data on serum epitope-specific antibodies (ESAs) and their association with neutralizing activity (NA) are limited. We aimed to evaluate ESA in healthy Japanese adults and their association with NA against various clinical isolates. Methods: Serum samples were collected from pediatricians from February to March 2020. ESA and NA levels were quantified by enzyme-linked immunosorbent assays and neutralizing assays. Pearson correlation analysis was used to estimate the association. Results: Ninety-two healthy adults aged 28 to 75 years were included. The ESA levels differed significantly across all sites. ESA levels were lower at sites IV and Ø (median [IQR], 2.7 μg/mL [2.2–3.4] and 10.2 [8.1–13.5], respectively) than at other sites (41.9 [35.0–56.7] at II, 16.6 [9.4–44.1] at III, and 35.3 [28.4–42.4] at V). Associations between ESA and NA levels differed by subtype and mutation. Conclusions: ESA and NA levels should be considered in the development and application of vaccines and monoclonal antibody therapies. Monitoring serum ESA levels and RSV fusion protein genes is essential for treatment selection.
- 18 July 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 233 (2) , 334-341
Respiratory Syncytial Virus Fusion Protein Epitope-Specific Antibodies and Neutralizing Activities Against Various Respiratory Syncytial Virus Strains
Background: Respiratory syncytial virus (RSV) fusion protein contains major neutralizing epitopes (sites II, III, IV, V, and Ø), targeted by new vaccines and monoclonal antibodies. However, data on serum epitope-specific antibodies (ESAs) and their association with neutralizing activity (NA) are limited. We aimed to evaluate ESA in healthy Japanese adults and their association with NA against various clinical isolates. Methods: Serum samples were collected from pediatricians from February to March 2020. ESA and NA levels were quantified by enzyme-linked immunosorbent assays and neutralizing assays. Pearson correlation analysis was used to estimate the association. Results: Ninety-two healthy adults aged 28 to 75 years were included. The ESA levels differed significantly across all sites. ESA levels were lower at sites IV and Ø (median [IQR], 2.7 μg/mL [2.2–3.4] and 10.2 [8.1–13.5], respectively) than at other sites (41.9 [35.0–56.7] at II, 16.6 [9.4–44.1] at III, and 35.3 [28.4–42.4] at V). Associations between ESA and NA levels differed by subtype and mutation. Conclusions: ESA and NA levels should be considered in the development and application of vaccines and monoclonal antibody therapies. Monitoring serum ESA levels and RSV fusion protein genes is essential for treatment selection.
- Open Access
- 12 January 2025
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 19 (1) , e70070
Temporal Trends in Respiratory Infection Epidemics Among Pediatric Inpatients Throughout the Course of the COVID‐19 Pandemic From 2018 to 2023 in Fukushima Prefecture, Japan
Background: Nonpharmaceutical interventions for coronavirus disease (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2, during the pandemic altered the epidemiology of respiratory viruses. This study aimed to determine the changes in respiratory viruses among children hospitalized from 2018 to 2023.Methods: Nasopharyngeal specimens were collected from children aged under 15 years with fever and/or respiratory symptoms admitted to a medical institution in Fukushima Prefecture between January 2018 and December 2023. Eighteen respiratory viruses were detected using real‐time reverse transcription‐polymerase chain reaction.Results: Overall, 1933 patients were included. Viruses were detected in 1377 (71.2%); of these, a single virus was detected in 906 (46.9%) and multiple viruses in 471 (24.3%). Among the viruses whose epidemics were temporarily suppressed, the epidemics of respiratory syncytial virus A and human parainfluenza virus type 3 (HPIV3) started earlier, and the epidemics of human metapneumovirus, HPIV1, and influenza A and C viruses resumed as behavioral restrictions for preventing COVID‐19 eased. The median age of children with airway infection was significantly higher in the postpandemic group than in the prepandemic group (18.0 months vs. 21.0 months, p < 0.01). The median age of children infected with HPIV3 and human rhinovirus was significantly higher in the postpandemic group than in the prepandemic group.Conclusions: Strengthening of nonpharmaceutical interventions changed the epidemic dynamics of pediatric infectious diseases, with a trend toward older hospitalized children. Continuous monitoring of pediatric infectious disease outbreaks in hospitalized children can help prepare for the emergence of future viruses and pandemics.
- 12 January 2025
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 19 (1) , e70070
Open AccessTemporal Trends in Respiratory Infection Epidemics Among Pediatric Inpatients Throughout the Course of the COVID‐19 Pandemic From 2018 to 2023 in Fukushima Prefecture, Japan
Background: Nonpharmaceutical interventions for coronavirus disease (COVID‐19), caused by severe acute respiratory syndrome coronavirus 2, during the pandemic altered the epidemiology of respiratory viruses. This study aimed to determine the changes in respiratory viruses among children hospitalized from 2018 to 2023.Methods: Nasopharyngeal specimens were collected from children aged under 15 years with fever and/or respiratory symptoms admitted to a medical institution in Fukushima Prefecture between January 2018 and December 2023. Eighteen respiratory viruses were detected using real‐time reverse transcription‐polymerase chain reaction.Results: Overall, 1933 patients were included. Viruses were detected in 1377 (71.2%); of these, a single virus was detected in 906 (46.9%) and multiple viruses in 471 (24.3%). Among the viruses whose epidemics were temporarily suppressed, the epidemics of respiratory syncytial virus A and human parainfluenza virus type 3 (HPIV3) started earlier, and the epidemics of human metapneumovirus, HPIV1, and influenza A and C viruses resumed as behavioral restrictions for preventing COVID‐19 eased. The median age of children with airway infection was significantly higher in the postpandemic group than in the prepandemic group (18.0 months vs. 21.0 months, p < 0.01). The median age of children infected with HPIV3 and human rhinovirus was significantly higher in the postpandemic group than in the prepandemic group.Conclusions: Strengthening of nonpharmaceutical interventions changed the epidemic dynamics of pediatric infectious diseases, with a trend toward older hospitalized children. Continuous monitoring of pediatric infectious disease outbreaks in hospitalized children can help prepare for the emergence of future viruses and pandemics.
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70244
Trends in pediatric bacterial meningitis incidence in Fukushima Prefecture, Japan, 1988–2024
- 1 January 2025
- Published by Wiley in Pediatrics International
- Vol. 67 (1) , e70244
Trends in pediatric bacterial meningitis incidence in Fukushima Prefecture, Japan, 1988–2024